Mackay Shields’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
Mackay Shields's PBYI Position: Q2 2019 in Review
Mackay Shields sold out of Puma Biotechnology (PBYI) in Q2 2019, closing a stake of 13,683 shares — an estimated $531K sold.
Mackay Shields first reported a position in PBYI in Q1 2018 and held it in 5 quarters. The position peaked at $776K in Q1 2018. 139 funds tracked by Wall St. Rank hold PBYI as of Q2 2019.
- Mackay Shields reported no remaining Puma Biotechnology position as of Q2 2019 after selling out during the quarter.
- Mackay Shields sold 13,683 Puma Biotechnology shares in Q2 2019, an estimated $531K.
- Mackay Shields first reported a position in Puma Biotechnology in Q1 2018 and held it in 5 quarters.
- Mackay Shields's Puma Biotechnology position peaked at $776K in Q1 2018.
- 139 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2019.
Based on Mackay Shields's 13F filing for Q2 2019, filed 13 Aug 2019.